Brigit A. de Jong - Concepedia

Author

Brigit A. de Jong

Also Known As

B A W De Jong, B A de Jong, B. A. De Jong, B. A. de Jong, B.A. de Jong, Brigit A De Jong, Brigit A de Jong, Brigit A. De Jong, Brigit A. de Jong, Claire Riley

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Location Vrije Universiteit Amsterdam Radboud University Nijmegen Amsterdam University Medical Centers

About

Brigit A. de Jong is an author at Amsterdam Neuroscience specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.3K
2	Public Health	2	2	135
3	Education	1	1	62
4	Engineering	1	1	26
5	Allergy	1	1	1.4K

Brigit A. de Jong

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. Gerard A. Schellekens, Brigit A. de Jong, F.H.J. van den Hoogen, Journal of Clinical Investigation ImmunologyPathologyImmunotherapyReactivity PatternInflammation	1998	1.4K
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study F. van Gaalen, Suzanne P. Linn-Rasker, W J van Venrooij, Arthritis & Rheumatism	2004	636
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis Robert C. Axtell, Brigit A. de Jong, Katia Boniface, Nature Medicine Cells Determine EfficacyAutoimmune DiseaseAdaptive Immune SystemMedicineImmunology	2010	530
The use of PROMs and shared decision‐making in medical encounters with patients: An opportunity to deliver value‐based health care to patients Olga C. Damman, Anant Jani, Brigit A. de Jong, Journal of Evaluation in Clinical Practice	2019	166
Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. W J Habets, M H Hoet, Brigit A. de Jong, The Journal of Immunology	1989	161
Production of IL-1β and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis Brigit A. de Jong, T. Huizinga, Eduard L. E. M. Bollen, Journal of Neuroimmunology InflammationCytokineAutoimmune DiseaseDisease ProgressionRelapse-onset Multiple Sclerosis	2002	117
IL-7 Promotes T <sub>H</sub> 1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis Li‐Fen Lee, Robert C. Axtell, Guang Huan Tu, Science Translational Medicine	2011	112
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy Laura van Berge, Eline M. Hamilton, Tarja Linnankivi, Brain	2014	105
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein Katja Herges, Brigit A. de Jong, Ilan Kolkowitz, Multiple Sclerosis Journal	2012	85
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic Zoë YGJ van Lierop, Alyssa A Toorop, Wouter JC van Ballegoij, Multiple Sclerosis Journal	2021	66

Page 1